Business and Technology News

Business, Life Sciences, and Technology News

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn’t the same as a human. But Horn, a veterinarian, says there are enough similarities between the species to take the science behind biological drugs for people and apply it to animals. […]

Join Xconomy on April 29 at Takeda Pharmaceuticals’ Boston location for the next in our Xcelerating Life Sciences event series: Biopharma’s Future in Digital Health. The half-day conference will bring together innovators, executives, rising pioneers, entrepreneurs, investors, and scientists to examine what’s fueling Boston’s biotech investment and partnership opportunities. As the nation’s largest biopharma cluster, […]

Three months after resTORbio’s lead drug failed a pivotal test treating lung infections in the elderly, the company is now looking for someone to buy the firm or strike a deal for its technology. In a corporate update issued Wednesday, resTORbio (NASDAQ: TORC) says it has started a process to evaluate “partnerships, acquisitions, mergers, and […]

Ligand Pharmaceuticals is adding neurological disease and cystic fibrosis programs to its pipeline through a deal to acquire assets from drug discovery company Icagen. San Diego-based Ligand (NASDAQ: LGND) is paying $15 million up front for the “core assets” of Icagen’s Durham, NC operations. The neuroscience program is being developed under a partnership with Roche […]

The FDA has placed a clinical hold on a LogicBio Therapeutics application to begin human testing of its experimental gene-editing therapy for a rare, inherited liver disorder. LogicBio (NASDAQ: LOGC) disclosed the clinical hold for its gene-editing therapy, LB-001, after Monday’s market close. The Cambridge, MA-based biotech said that the hold concerns “certain clinical and […]

Section Page news and features from Crain's New York Business

A Democratic party-tied consulting giant is enlarging its own tent—and started this week by absorbing a New York corporate public relations house. most powerful politicians in New York and the...

To view the full story, click the title link.

A snapshot of the city's construction workforce found that a majority reside in the five boroughs. The report, produced by the New York Building Congress, found that 73.7% of the construction...

To view the full story, click the title link.

Gov. Andrew Cuomo says the Trump administration is holding New York travelers and exporters hostage—and he won't accept his ransom.The governor signaled Friday that he is willing to divulge even...

To view the full story, click the title link.

Community Access—a nonprofit focused on supportive housing and social services for city residents with mental health concerns—is spearheading a pair of new developments in the Bronx.A $91 million,...

To view the full story, click the title link.

There was a chorus outside the Broadway Theatre on Thursday at the opening night of a new revival of “West Side Story” but what was being sung was a protest chant.A group of about 100 people...

To view the full story, click the title link.

Corporations are pouring money into competitive rock-climbing, fueling a boom in gyms from New York to Dallas where wannabe alpinists scale artificial heights in pricey gear. But even with the sport...

To view the full story, click the title link.

The move could hamstring the Chinese tech giant if it prevents the firm’s customers from getting the latest versions of services such as Maps and Gmail.

Shareholders are voting on whether to push the tech giant to examine the human rights and financial risks of the surveillance technology.

Artificial intelligence may help doctors make more accurate readings of CT scans used to screen for lung cancer.

The great hope for people without a bachelor’s degree hasn’t yet spread beyond small-scale success stories.

When it comes to disinformation, all signs suggest the 2020 presidential campaign will make 2016 look like a mere test run, our columnist writes.

The price was relatively small, but the deal may have a big impact on the race between the United States and China to build more powerful computers.